Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 10 years
- Director since
- 2020
10 years of board service in total across 2 boards, counting each seat separately. Longest: Bruker Corporation, 6 years.
Bruker Corporation
Director
Veracyte Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 15, 2025 | Bruker Corporation | Grant or award | +3,298 | — | — |
| Jan 5, 2024 | Bruker Corporation | Grant or award | +2,377 | — | — |
| Jun 2, 2023 | Veracyte Inc. | Shares withheld for tax | −1,304 | $26.72 | $34,843 |
| Apr 14, 2023 | Veracyte Inc. | Option exercise | +34,000 | $5.61 | $190,740 |
| Apr 14, 2023 | Veracyte Inc. | Open-market sale | −34,000 | $22.04 | $749,360 |
| Mar 15, 2023 | Veracyte Inc. | Option exercise | +34,000 | $5.61 | $190,740 |
| Mar 15, 2023 | Veracyte Inc. | Open-market sale | −34,000 | $22.76 | $773,840 |
| Mar 2, 2023 | Veracyte Inc. | Shares withheld for tax | −8,994 | $24.10 | $216,755 |
| Jan 17, 2023 | Veracyte Inc. | Option exercise | +34,000 | $5.61 | $190,740 |
| Jan 17, 2023 | Veracyte Inc. | Open-market sale | −29,506 | $26.30 | $776,008 |
| Jan 17, 2023 | Veracyte Inc. | Open-market sale | −4,494 | $26.64 | $119,720 |
| Jan 11, 2023 | Veracyte Inc. | Option exercise | +63,247 | $14.34 | $906,962 |
| Jan 11, 2023 | Veracyte Inc. | Open-market sale | −63,247 | $25.13 | $1,589,397 |
| Jan 5, 2023 | Bruker Corporation | Grant or award | +1,970 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.